The Day After COVID-19—Time to Rethink Oncology Clinical Research
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
JAMA Oncology, sous presse, 2020, article en libre accès
Résumé en anglais
The declaration of the coronavirus disease 2019 (COVID-19) as a pandemic by the World Health Organization on March 11, 2020, has led to unprecedented measures such as social distancing and economic lockdown by many international governments to combat viral spread and to prevent health care systems from collapsing. Regardless of its ensuing course, the pandemic’s effect will undoubtedly linger in many aspects of cancer care and research, including oncology clinical trials.
